Emyria Ltd: So crazy it might just work – psychedelic drugs to treat mental health

Listen to ASX-listed Emyria Ltd Managing Director Dr Michael Winlo talk to Matt Birney on the Bulls N’ Bears Report about Emyria’s research and development of “party drug” MDMA to tackle the $219b a year mental health market.